1. Home
  2. NKTR vs SCD Comparison

NKTR vs SCD Comparison

Compare NKTR & SCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • SCD
  • Stock Information
  • Founded
  • NKTR 1990
  • SCD 2003
  • Country
  • NKTR United States
  • SCD United States
  • Employees
  • NKTR N/A
  • SCD N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • SCD Trusts Except Educational Religious and Charitable
  • Sector
  • NKTR Health Care
  • SCD Finance
  • Exchange
  • NKTR Nasdaq
  • SCD Nasdaq
  • Market Cap
  • NKTR 108.3M
  • SCD 272.7M
  • IPO Year
  • NKTR 1994
  • SCD N/A
  • Fundamental
  • Price
  • NKTR $24.48
  • SCD $15.97
  • Analyst Decision
  • NKTR Strong Buy
  • SCD
  • Analyst Count
  • NKTR 6
  • SCD 0
  • Target Price
  • NKTR $77.50
  • SCD N/A
  • AVG Volume (30 Days)
  • NKTR 4.6M
  • SCD 62.6K
  • Earning Date
  • NKTR 08-07-2025
  • SCD 01-01-0001
  • Dividend Yield
  • NKTR N/A
  • SCD 9.63%
  • EPS Growth
  • NKTR N/A
  • SCD N/A
  • EPS
  • NKTR N/A
  • SCD N/A
  • Revenue
  • NKTR $87,248,000.00
  • SCD N/A
  • Revenue This Year
  • NKTR N/A
  • SCD N/A
  • Revenue Next Year
  • NKTR N/A
  • SCD N/A
  • P/E Ratio
  • NKTR N/A
  • SCD N/A
  • Revenue Growth
  • NKTR N/A
  • SCD N/A
  • 52 Week Low
  • NKTR $6.48
  • SCD $11.33
  • 52 Week High
  • NKTR $37.38
  • SCD $15.87
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 68.00
  • SCD 54.72
  • Support Level
  • NKTR $8.27
  • SCD $15.58
  • Resistance Level
  • NKTR $26.59
  • SCD $15.78
  • Average True Range (ATR)
  • NKTR 3.71
  • SCD 0.30
  • MACD
  • NKTR 1.18
  • SCD 0.00
  • Stochastic Oscillator
  • NKTR 57.06
  • SCD 94.95

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

About SCD LMP Capital and Income Fund Inc.

Lmp Capital & Income Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is total return with an emphasis on income. The fund invests in a broad range of equity and fixed-income securities of both the U.S. and foreign issuers. Its long-term investments consists of investments in common stocks, convertible preferred stocks, investments in underlying funds and master limited partnerships. Maximum investment in Sales in the IT sector, Cheniere Energy in the energy sector, Ares Management and U.S. Bancorp in the financials sector and Lennar in the consumer discretionary sector, and etc.

Share on Social Networks: